|
|
Volumn 13, Issue 2, 2012, Pages 111-
|
|
Ovarian cancer: Breaking the silence
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AFLIBERCEPT;
BEVACIZUMAB;
CARBOPLATIN;
PACLITAXEL;
PLACEBO;
ABDOMINAL SWELLING;
ADVANCED CANCER;
ANOREXIA;
AWARENESS;
CANCER COMBINATION CHEMOTHERAPY;
CANCER DIAGNOSIS;
CANCER MORTALITY;
CANCER STAGING;
CANCER SURGERY;
CANCER SURVIVAL;
CLINICAL RESEARCH;
DRUG EFFICACY;
DRUG SAFETY;
EDITORIAL;
HUMAN;
OVARY CANCER;
PARACENTESIS;
PRIORITY JOURNAL;
PROGRESSION FREE SURVIVAL;
SURVIVAL RATE;
TREATMENT RESPONSE;
CLINICAL TRIALS, PHASE III AS TOPIC;
COMBINED MODALITY THERAPY;
FEMALE;
HUMANS;
OVARIAN NEOPLASMS;
|
|
EID: 84856436625
PISSN: 14702045
EISSN: 14745488
Source Type: Journal
DOI: 10.1016/S1470-2045(12)70052-9 Document Type: Editorial |
|
Times cited : (5)
|
|
References (0)
|